Determination of the mutant-prevention concentration of imipenem for the two imipenem-susceptible Bacteroides fragilis strains, Q1F2 (cfiA-positive) and ATCC 25282 (cfiA-negative)

Int J Antimicrob Agents. 2018 Feb;51(2):270-271. doi: 10.1016/j.ijantimicag.2017.08.004. Epub 2017 Aug 4.

Authors

Pak-Leung Ho¹, Chong-Yee Yau², Ya Wang², Kin-Hung Chow²

Affiliations

¹ Department of Microbiology and Carol Yu Centre for Infection, The University of Hong Kong, Queen Mary Hospital, Hong Kong, People's Republic of China. Electronic address: plho@hku.hk.
² Department of Microbiology and Carol Yu Centre for Infection, The University of Hong Kong, Queen Mary Hospital, Hong Kong, People's Republic of China.

PMID: 28782706
DOI: 10.1016/j.ijantimicag.2017.08.004

No abstract available

Publication types

Letter

MeSH terms

Anti-Bacterial Agents / pharmacology*
Bacterial Proteins / drug effects
Bacterial Proteins / genetics*
Bacteroides fragilis / drug effects*
Bacteroides fragilis / genetics*
Drug Resistance, Bacterial / genetics*
Imipenem / pharmacology*
Microbial Sensitivity Tests
Mutation / drug effects*
beta-Lactamases / drug effects
beta-Lactamases / genetics*

Substances

Anti-Bacterial Agents
Bacterial Proteins
Imipenem
beta-Lactamases
carbapenemase